Karin Hohloch

7PUBLICATIONS
6CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Central nervous systemRadiation therapyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 18, 2022
Low serum albumin is an independent risk factor in elderly patients with aggressive B-cell lymphoma: Results from prospective trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group.

Karin Hohloch, Marita Ziepert, Lorenz Truemper

|May 10, 2022
SAKK 35/15: a phase 1 trial of obinutuzumab in combination with venetoclax in patients with previously untreated follicular lymphoma.

Anastasios Stathis, Ulrich Mey, Sämi Schär

|Mar 04, 2020
Radioimmunotherapy for mantle cell lymphoma: 5-year follow-up of 90 patients from the international RIT registry.

Karin Hohloch, Christine Windemuth-Kieselbach, Pier Luigi Zinzani

|Jul 20, 2019
Cerebral salt wasting in a patient with myeloproliferative neoplasm.

Lea Orlik, Reto Venzin, Thomas Fehr

|Dec 06, 2018
Radioimmunotherapy (RIT) for Follicular Lymphoma achieves long term lymphoma control in first line and at relapse: 8-year follow-up data of 281 patients from the international RIT-registry.

Karin Hohloch, Christiane Windemuth-Kieselbach, Julia Kolz

|Dec 02, 2017
Obesity negatively impacts outcome in elderly female patients with aggressive B-cell lymphomas treated with R-CHOP: results from prospective trials of the German high grade non-Hodgkin's lymphoma trial group.

K Hohloch, B Altmann, M Pfreundschuh

Pageof 2

Frequent Collaborators

1 joint publications

Pier Luigi Zinzani

1 joint publications

Nicolas Mach

1 joint publications

Stefanie Hayoz

1 joint publications

Luca Ceriani